Acasti Pharma reported $1.24M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Addus HomeCare USD 149.49M 7.31M Dec/2025
Amarin USD 194.46M 12.23M Dec/2025
Cassava Sciences USD 43.83M 4.21M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Option Care Health USD 829.35M 5.44M Dec/2025
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Tilray USD 259.32M 8.32M Sep/2025